William Guyer Corcept Therapeutics Inc (CORT) insider trading activity

William Guyer is Chief Development Officer of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 5,487 shares of CORT, which is worth approximately $379,041. The most recent transaction as insider was on Jul 18, 2025, when has been sold 500 shares (Common Stock) at a price of $73.44 per share, resulting in proceeds of $36,720. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49K

0% 3M change

9.14% 12M change

Total Value Held $379,041

William Guyer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 18 2025	SELL Open market or private sale	$36,720 $73.44 p/Share	500 Reduced 8.35%	5,487 Common Stock
Jul 18 2025	BUY Exercise of conversion of derivative security	$10,825 $21.65 p/Share	500 Added 7.71%	5,987 Common Stock
Jul 17 2025	SELL Open market or private sale	$321,768 $73.48 p/Share	4,379 Reduced 44.38%	5,487 Common Stock
Jul 17 2025	BUY Exercise of conversion of derivative security	$94,805 $21.65 p/Share	4,379 Added 30.74%	9,866 Common Stock
Jul 01 2025	SELL Open market or private sale	$7,350 $73.5 p/Share	100 Reduced 1.79%	5,487 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	$2,165 $21.65 p/Share	100 Added 1.76%	5,587 Common Stock
Jun 10 2025	SELL Open market or private sale	$1,451,200 $72.56 p/Share	20,000 Reduced 78.47%	5,487 Common Stock
Jun 10 2025	BUY Exercise of conversion of derivative security	$433,000 $21.65 p/Share	20,000 Added 43.97%	25,487 Common Stock
May 16 2025	SELL Open market or private sale	$2,392,872 $74.17 p/Share	32,262 Reduced 85.46%	5,487 Common Stock
May 16 2025	BUY Exercise of conversion of derivative security	$698,472 $21.65 p/Share	32,262 Added 46.08%	37,749 Common Stock
May 06 2025	SELL Open market or private sale	$524,628 $74.31 p/Share	7,060 Reduced 56.27%	5,487 Common Stock
May 06 2025	BUY Exercise of conversion of derivative security	$152,849 $21.65 p/Share	7,060 Added 36.01%	12,547 Common Stock
Apr 01 2025	SELL Open market or private sale	$77,637 $114.51 p/Share	678 Reduced 11.0%	5,487 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	$14,678 $21.65 p/Share	678 Added 9.91%	6,165 Common Stock
Mar 04 2025	SELL Open market or private sale	$1,181,400 $59.07 p/Share	20,000 Reduced 78.47%	5,487 Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	$385,200 $19.26 p/Share	20,000 Added 43.97%	25,487 Common Stock
Dec 02 2024	SELL Payment of exercise price or tax liability	$17,823 $57.68 p/Share	309 Reduced 5.33%	5,487 Common Stock
Nov 04 2024	SELL Open market or private sale	$166,204 $48.97 p/Share	3,394 Reduced 36.93%	5,796 Common Stock
Nov 04 2024	BUY Exercise of conversion of derivative security	$73,480 $21.65 p/Share	3,394 Added 26.97%	9,190 Common Stock
Nov 01 2024	SELL Open market or private sale	$323,495 $48.97 p/Share	6,606 Reduced 53.27%	5,796 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$143,019 $21.65 p/Share	6,606 Added 34.75%	12,402 Common Stock
Oct 01 2024	SELL Open market or private sale	$462,800 $46.28 p/Share	10,000 Reduced 63.31%	5,796 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$216,500 $21.65 p/Share	10,000 Added 38.77%	15,796 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$8,577 $35.3 p/Share	243 Reduced 4.02%	5,796 Common Stock
Sep 03 2024	SELL Open market or private sale	$353,000 $35.3 p/Share	10,000 Reduced 62.35%	6,039 Common Stock

William Guyer

Chief Development Officer

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account